Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 492-498

  Tonacchera, Massimo ^a   Chiovato, Luca ^a   Pinchera, Aldo ^a   Agretti, Patrizia ^a   Fiore, Emilio ^a   Cetani, Filomena ^a   Rocchi, Roberto ^a   Viacava, Paolo ^a   Miccoli, Paolo ^a   Vitti, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; EXON; FEMALE; GENE MUTATION; HUMAN; HYPERTHYROIDISM; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THYROID ADENOMA; THYROID NODULE; TOXIC GOITER;

ADENOMA; ADULT; ANIMALS; COS CELLS; CYCLIC AMP; DNA; FEMALE; GENE EXPRESSION; GOITER, NODULAR; HUMANS; MALE; MIDDLE AGED; MUTATION; RECEPTORS, THYROTROPIN; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN; TRANSFECTION;

EID: 15144351998     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.492     Document Type: Article

References (35)

1. Hay ID, Morris JC. 1996 Toxic adenoma and toxic multinodular goiter. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. Philadelphia: Lippincott-Raven; 566-572.
2. Hamburger JI. 1987 The autonomously functioning thyroid nodule: Goetsch's disease. Endocr Rev. 8:439-450.
3. Wiener JD. 1987 Plummer's disease: localized thyroid autonomy. J Endocrinol Invest. 10:207-224.
4. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
5. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
6. ++ cascades. Mol Endocrinol. 9:725-733.
7. Porcellini A, Ciullo I, Laviola L, Amabile A, Fenzi G, Avvedimento V. 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:657-661.
8. Takeshita A, Nagayama Y, Yokoyama N, et al. 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab. 1195:80:2607-2610.
9. Porcellini A, Tassi V, Ciullo I, et al. 1995 Studies on the prevalence of TSH receptor mutations in a large series of consecutive hyperfunctioning adenomas. Thyroid. 5[Suppl 1]:S-8. (Abstract).
10. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
11. Kopp P, Wilkes B, Gu WX, Jameson JL. 1997 Absence of mutations in the TSH receptor and the Gsα subunit in nodules and adenomas of multinodular goiters and identification of a new activating mutation (Tyr 601 Asp) in a solitary toxic adenoma. Thyroid 6[Suppl 1]:S-9. (Abstract).
12. Brunn J, Blocjk U, Ruf J, Bos I Kunze WP, Scriba PC. 1983 Volumetrie der Schildrusenlappen mittels real-time sonographie. Dtsch Med J. 287:1206-1207.
13. Tonacchera M, Van Sande J, Cetani F, et al. 1996 Functional characteristics of three new germline mutations of the TSH receptor gene causing autosomal dominant toxic hyperplasia. J Clin Endocrinol Metab. 81:547-554.
14. Tabor S, Richardson CC. 1989 Selective inactivation of the exonuclease activity of bacteriophage T7 DNA polymerase by in vitro mutagenesis. J Biol Chem. 264:6447-6458.
15. Vitti P, Chiovato L, Ceccarelli P, et al. 1986 Thyroid stimulating antibody mimics thyrotropin in its ability to desensitize 3′-5′-monophosphate response to acute stimulation in continuously cultured thyroid cells (FRT-L5). J Clin Endocrinol Metab. 454-458.
16. Rapoport B, Seto P. 1985 Bovine thyrotropin has a specific bioactivity 5- to 10-fold that of previous estimates for highly purified hormone. Endocrinology 116:1379-1382.
17. Swillens S. 1995 Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis. Mol Pharmacol 47:1197-1203.
18. Duprez L, Parma J, Dumont JE, Hermans J, Vassart G. 1996 Diversity and prevalence of somatic mutations in the TSH receptor gene as a cause of toxic adenoma. J Endocrinol Invest. 19[Suppl 6]:69. (Abstract).
19. Paschke R, Fuehrer D, Holzapfel HP. 1996 Identification of different thyrotropin receptor mutations in toxic multinodular goiter. J Endocrinol Invest. 19[Suppl 6]:28. (Abstract).
20. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont JE, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases J Clin Endocrinol Metab. 80:2577-2585.
21. Kosugi S, Shenker A, Mori T. 1994 Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human TSH receptor. FEBS Lett. 356:291-294.
22. Porcellini A, Ciullo I, Pannain S, Fenzi GF, Awedimento E 1995 Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas Oncogene. 11:1089-1093.
23. Peter HJ, Studer H, Forster R, Gerber H. 1982 The pathogenesis of hot and cold follicles in multinodular goiters. J Clin Endocrinol Metab. 55:941-946.
24. Studer H, Peter HJ, Gerber H. 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth Endocr Rev. 10:125-135.
25. Studer H, Gerber H, Zbaeren J, Peter HJ. 1992 Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab. 875:1151-1158.
26. Studer H, Derwahl M. 1995 Mechanisms of nonneoplastic endocrine hyperplasia: a changing concept: a review focused on the thyroid gland. Endocr Rev. 16:411-426.
27. Belfiore A, Sava L, Runello F, Tomaselli L, Vigneri R. 1983 Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab. 56:283-287.
28. Dremier S, Coppee F, Delange F, Vassart G, Dumont JE, Van Sande J. 1996 Thyroid autonomy; mechanism and clinical effects. J Clin Endocrinol Metab. 81:4187-4193.
29. Als C, Listewnik M, Rosler H, Bartkowiak E. 1995 Immunogenic and non immunogenic hyperthyroidism. Nucl Med. 34:92-99.
30. Baltisberger BL, Minder CE, Burgi H. 1995 Decrease of incidence of toxic nodular goiter in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol. 132:546-549.
31. Tonacchera M, Cetani F, Parma J, Van Sande J, Vassart G, Dumont J. 1996 Oncogenic mutations in thyroid adenoma: methodological criteria. Eur J Endocrinol. 135:444-446.
32. Tonacchera M, Van Sande J, Parma J, et al. 1996 TSH receptor and disease. Clin Endocrinol (Oxf). 44:621-633.
33. O'Sullivan C, Barton CM, Staddon S, Brown CL, Lemoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogen. 4:345-349.
34. Dumont JE, Lamy F, Roger P, Maenhaut C. 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72:667-697.
35. Parma J, Duprez L, Van Sande J, et al. 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:2695-2701.